<DOC>
	<DOCNO>NCT01801722</DOCNO>
	<brief_summary>The aim present study evaluate analysis NT-proBNP might use initial step diagnosis chronic heart failure patient COPD primary health care , select patient examination echocardiography .</brief_summary>
	<brief_title>Using NT-proBNP Detect Chronic Heart Failure Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Patients confirm diagnosis COPD examine regard chronic heart failure . 1 . An interview regard symptom : breathlessness , orthopnoea , night cough , nocturia , walk distance . 2 . Physical examination : weight height , heart lung auscultation , blood pressure measurement 5 minute ' rest sit position presence peripheral oedema . 3 . Electrocardiography . 4 . Natriuretic peptide- NT-proBNP ( Immulite 2500 , Siemens Healthcare Diagnostics AB Sweden ) . 5 . Patients NT-proBNP level &gt; 1200 pg/ml refer echocardiography ass leave ventricular function .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patients age 65 year old follow diagnosis code accord International Statistical Classification Diseases Related Health Problems Tenth Revision : J44 ( COPD ) J41 , J42 ( chronic bronchitis ) register period 1 January 200816 April 2008 accord electronic patient record . Impaired cognitive function and/or anticipate difficulty carry spirometry due immobility , psychiatric disorder terminal illness .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>